Your session is about to expire
← Back to Search
Behavioral Intervention
Nurse-Led Phone Support for Heart Failure (CARE-HF Trial)
N/A
Recruiting
Led By Lucinda J Graven, PhD
Research Sponsored by Florida State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Diagnosed with heart failure (reduced or preserved ejection fraction)
Age 18 years of age or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18-months
Awards & highlights
No Placebo-Only Group
Summary
This trial tests a phone-based program, run by nurses, to improve physical and mental health in Veterans with heart failure. It's done in the US and monitored for 18 months.
Who is the study for?
This trial is for US Veterans aged 18 or older who have been diagnosed with heart failure, regardless of the type. Participants must be able to read, speak, and understand English and have reliable telephone access. Those with a history of cognitive dysfunction cannot join.
What is being tested?
The study tests a tailored telehealth program called Care-HF designed for veterans with heart failure. It involves working with a nurse over the phone for 12 weeks, including eight sessions aimed at improving physical and mental health.
What are the potential side effects?
Since this intervention is non-medical and involves only telephone-based problem-solving sessions, there are no direct medical side effects associated with drugs or procedures.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with heart failure.
Select...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 18-months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18-months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Anxiety
Depression
Heart Failure Self-care
+1 moreSecondary study objectives
Coping
Health Related Quality of Life
Healthcare Utilization
+2 moreOther study objectives
Problem-Solving
Social Support
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: CARE-HFExperimental Treatment1 Intervention
The problem-solving intervention will be led by a registered nurse. Participants will receive a program manual containing examples of common HF-related problems experienced by heart failure patients and suggested management strategies, with some strategies tailored to the rural sociocultural context. The nurse will lead participants in a card sorting task intended to help participants prioritize current HF-related problems and will guide participants in developing management strategies for the highest priority problem(s). Participants will utilize these strategies until the next session at which time the nurse will guide participants in evaluating the effectiveness of chosen strategies. The iterative process then begins again. Participants will receive 7 follow-up telephone sessions with the nurse. In the intervention, the nurse will focus on problems related to self-care, disease management, mental health, and quality of life, including those specific to the rural population.
Find a Location
Who is running the clinical trial?
Florida State UniversityLead Sponsor
224 Previous Clinical Trials
36,541 Total Patients Enrolled
US Department of Veterans AffairsFED
875 Previous Clinical Trials
498,321 Total Patients Enrolled
Lucinda J Graven, PhDPrincipal InvestigatorFlorida State University College of Nursing
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a history of problems with memory or thinking.You are a veteran of the United States military.I have been diagnosed with heart failure.I am 18 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: CARE-HF
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.